NDC 68229-102-01 - Clinere Ear Wax Remover
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68229-102
- Requested NDC
- 68229-102-01
- Package NDCs from labels
- 68229-102-01, 68229-102-03, 68229-102-02
- Manufacturer
- Quest Products
- Effective date
- 2026-01-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clinere Ear Wax Remover - Quest Products | Quest Products | 2026-01-08 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68229-102-01 | Clinere Ear Wax Remover | 15 mL in 1 BOTTLE | LIQUID | 15 | 4 | |
| 68229-102-02 | Clinere Ear Wax Remover | 1 in 1 CARTON | LIQUID | 1 | 4 | |
| 68229-102-03 | Clinere Ear Wax Remover | 2 in 1 CARTON | LIQUID | 2 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68229-102-02 | ML - Milliliter | 68229-102 | cb2b9467-aa84-4bce-8be1-cc2b8ebde26e | 1 | 2022-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dry Eye Relief Sterile Lubricant Eye Drops | GLYCERIN | Similasan Corporation | 4c4cce1c-392e-354d-e063-6294a90a0ca3 | 2026-03-05 | Warnings | PDC6A3C0OX |
| Sore Throat | PHENOL GLYCERIN | CVS PHARMACY, INC | 9683bcfb-2f7e-48a4-aa79-500ee8df099a | 2026-03-02 | Warnings | PDC6A3C0OX |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | PDC6A3C0OX |
| Ear Wash Refill CVS | CARBAMIDE PEROXIDE | CVS | 311c5951-949c-b38b-e063-6294a90aa4a9 | 2026-02-27 | Warnings | M014 702050 |
| Dermatool Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Papalo Group LLC | 4bc06f41-7733-ebd0-e063-6294a90af7a8 | 2026-02-26 | Warnings | PDC6A3C0OX |
| Tricitrates | TRICITRATES | Chartwell Governmental & Specialty RX, LLC. | c4ff0407-3930-4c48-afd4-d2cb3e1b18f4 | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP 1Q73Q2JULR |
| Potassium Citrate and Citric Acid | POTASSIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC. | fd57a176-7faf-4053-b348-6ba5f192f05a | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| ProRinse Earwax Removal System | CARBAMIDE PEROXIDE | McKeon Products Inc | ca82db28-1ef7-41c6-a46b-7bfc7b09281c | 2026-02-09 | Warnings | M014 702050 31PZ2VAU81 |
| Wax Away Earwax Removal Aid | CARBAMIDE PEROXIDE | McKeon Products Inc | 8e6c8bf3-d3ec-4605-b8e5-47612f94db89 | 2026-02-09 | Warnings | M014 702050 31PZ2VAU81 |
| Wax Away Earwax Removal System | CARBAMIDE PEROXIDE | McKeon Products Inc | 22c6f7db-814b-4e70-9fbe-bbb86385d070 | 2026-02-09 | Warnings | M014 702050 31PZ2VAU81 |
| Droptics Performance Eye Drops | NAPHAZOLINE HYDROCHLORIDE, PROPYLENE GLYCOL | Droptics LLC | 20fd6822-a7fd-4593-92bb-0a07260893e2 | 2026-02-09 | Warnings | 6DC9Q167V3 |
| blue goo FREEZING PAIN RELIEF Topical Analgesic | MENTHOL 4% | Garcoa, Inc. | e90e35e8-47a7-4f9b-ba8a-1cfd15b43995 | 2026-02-06 | Warnings | M014 |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 2968PHW8QP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.